In ERα+/PR+/HER2+ cells, a greater decrease in cell proliferation was observed when the treatments applied individually or in combination did not increase the CIN above 68% (Figures 6 and 7, and Supplementary Table S2). The gene discussed is ERBB2; the disease is cervical squamous intraepithelial neoplasia.